ERBB2 and lung carcinoma: The cell-cycle effects we saw in MCF-7-TR tamoxifen-resistant cells were in keeping with a report by Suzawa et al. [32], who showed induction of apoptosis in lung cancer cells with HER2 mutations with exquisite sensitivity to afatinib.